Literature DB >> 9405615

Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family.

T A Samad1, W Krezel, P Chambon, E Borrelli.   

Abstract

Dopamine is a neuromodulator involved in the control of key physiological functions. Dopamine-dependent signal transduction is activated through the interaction with membrane receptors of the seven-transmembrane domain G protein-coupled family. Among them, dopamine D2 receptor is highly expressed in the striatum and the pituitary gland as well as by mesencephalic dopaminergic neurons. Lack of D2 receptors in mice leads to a locomotor parkinsonian-like phenotype and to pituitary tumors. The D2 receptor promoter has characteristics of a housekeeping gene. However, the restricted expression of this gene to particular neurons and cells points to a strict regulation of its expression by cell-specific transcription factors. We demonstrate here that the D2 receptor promoter contains a functional retinoic acid response element. Furthermore, analysis of retinoic acid receptor-null mice supports our finding and shows that in these animals D2 receptor expression is reduced. This finding assigns to retinoids an important role in the control of gene expression in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405615      PMCID: PMC24972          DOI: 10.1073/pnas.94.26.14349

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

2.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

Review 3.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

4.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors.

Authors:  J H Baik; R Picetti; A Saiardi; G Thiriet; A Dierich; A Depaulis; M Le Meur; E Borrelli
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

Review 5.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

Authors:  D M Jackson; A Westlind-Danielsson
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

6.  Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia.

Authors:  A Saiardi; Y Bozzi; J H Baik; E Borrelli
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

7.  Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.

Authors:  A M Judd; I S Login; K Kovacs; P C Ross; B L Spangelo; W D Jarvis; R M MacLeod
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

8.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

Authors:  V Kumar; P Chambon
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  The dopamine D2 receptor: two molecular forms generated by alternative splicing.

Authors:  R Dal Toso; B Sommer; M Ewert; A Herb; D B Pritchett; A Bach; B D Shivers; P H Seeburg
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  45 in total

1.  Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Jae Kim; Scott M Rawls; Dianne Langford
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

Review 2.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

4.  Working memory deficits in retinoid X receptor gamma-deficient mice.

Authors:  Marta Wietrzych; Hamid Meziane; Anne Sutter; Norbert Ghyselinck; Paul F Chapman; Pierre Chambon; Wojciech Krezel
Journal:  Learn Mem       Date:  2005-05-16       Impact factor: 2.460

5.  An integrative genomics approach to infer causal associations between gene expression and disease.

Authors:  Eric E Schadt; John Lamb; Xia Yang; Jun Zhu; Steve Edwards; Debraj Guhathakurta; Solveig K Sieberts; Stephanie Monks; Marc Reitman; Chunsheng Zhang; Pek Yee Lum; Amy Leonardson; Rolf Thieringer; Joseph M Metzger; Liming Yang; John Castle; Haoyuan Zhu; Shera F Kash; Thomas A Drake; Alan Sachs; Aldons J Lusis
Journal:  Nat Genet       Date:  2005-06-19       Impact factor: 38.330

6.  Role of retinoic acid during forebrain development begins late when Raldh3 generates retinoic acid in the ventral subventricular zone.

Authors:  Natalia Molotkova; Andrei Molotkov; Gregg Duester
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

7.  Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Authors:  Jose A Rodríguez-Gómez; Jian-Qiang Lu; Iván Velasco; Seth Rivera; Sami S Zoghbi; Jeih-San Liow; John L Musachio; Frederick T Chin; Hiroshi Toyama; Jurgen Seidel; Michael V Green; Panayotis K Thanos; Masanori Ichise; Victor W Pike; Robert B Innis; Ron D G McKay
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

8.  Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat.

Authors:  Ken Fujiwara; Bulgan Davaadash; Megumi Yatabe; Motoshi Kikuchi; Kotaro Horiguchi; Kenji Kusumoto; Tom Kouki; Takashi Yashiro
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

9.  Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation.

Authors:  Marcos Roberto de Oliveira; Roberta Bristot Silvestrin; Tadeu Mello e Souza; José Cláudio Fonseca Moreira
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

Review 10.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.